Literature DB >> 8523521

Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light.

K Tsung1, J H Yim, W Marti, R M Buller, J A Norton.   

Abstract

Induction of the cytopathic effect (CPE) in cells infected with poxvirus seems ubiquitous in that it has been associated with all different strains and preparations of poxviruses, regardless of the replicating status of these viruses. The study of the mechanisms by which CPE is induced by nonreplicating poxviruses is hampered by the lack of any noncytopathic mutant strains and preparations. In this paper, we report on the patterns of gene expression and induction of CPE by vaccinia viruses treated by limited cross-linking with psoralen and long-wave UV light (PLWUV). We show that treatment of cell-free virus with PLWUV could inactivate viral replication without abolishing the ability of the virus to infect cells. Viral transcription as indicated by reporter genes was generally enhanced and prolonged under early viral promoters and abolished under late promoters. Furthermore, increasing the levels of cross-linking with PLWUV resulted in a decrease and abolishment of viral expression of a large reporter gene and a concomitant loss of the induction of CPE. Cells infected with such a virus were able to express the reporter genes and proliferate. The generation of nonreplicating and noncytopathic recombinant vaccinia viruses may help in studies of the mechanisms of CPE induction by poxvirus and may facilitate the use of poxviral vectors in broader areas of research and clinical applications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8523521      PMCID: PMC189801     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Structural and functional alterations in cultured cells infected with cytocidal viruses.

Authors:  R Balanian
Journal:  Prog Med Virol       Date:  1975

2.  Early transcription factor subunits are encoded by vaccinia virus late genes.

Authors:  P D Gershon; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  Structure of vaccinia virus early promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

4.  The prevention of early vaccinia-virus-induced cytopathic effects by inhibition of protein synthesis.

Authors:  R Bablanian
Journal:  J Gen Virol       Date:  1968-07       Impact factor: 3.891

5.  Vaccinia mRNA synthesis under conditions which prevent uncoating.

Authors:  B Woodson
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

6.  Inhibition of cellular protein synthesis by vaccinia virus surface tubules.

Authors:  G N Mbuy; R E Morris; H C Bubel
Journal:  Virology       Date:  1982-01-15       Impact factor: 3.616

7.  Inhibition of HeLa cell protein synthesis by the vaccinia virion.

Authors:  B Moss
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

8.  Studies on the mechanisms of vaccinia virus cytopathic effects. II. Early cell rounding is associated with virus polypeptide synthesis.

Authors:  R Bablanian; B Baxt; J A Sonnabend; M Esteban
Journal:  J Gen Virol       Date:  1978-06       Impact factor: 3.891

Review 9.  An update on the vaccinia virus genome.

Authors:  G P Johnson; S J Goebel; E Paoletti
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

10.  Heat-stable antigen is a costimulatory molecule for CD4 T cell growth.

Authors:  Y Liu; B Jones; A Aruffo; K M Sullivan; P S Linsley; C A Janeway
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  43 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Optimizing high dimensional gene expression studies for immune response following smallpox vaccination using Taqman® low density immune arrays.

Authors:  Ann L Oberg; Neelam Dhiman; Diane E Grill; Jenna E Ryan; Richard B Kennedy; Gregory A Poland
Journal:  J Immunol Methods       Date:  2011-01-28       Impact factor: 2.303

3.  A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading.

Authors:  Makoto Inoue; Yumiko Tokusumi; Hiroshi Ban; Takumi Kanaya; Masayuki Shirakura; Tsuyoshi Tokusumi; Takahiro Hirata; Yoshiyuki Nagai; Akihiro Iida; Mamoru Hasegawa
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

4.  Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta.

Authors:  Jiangao Zhu; Jennifer Martinez; Xiaopei Huang; Yiping Yang
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

5.  Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.

Authors:  José Luis Nájera; Carmen Elena Gómez; Elena Domingo-Gil; María Magdalena Gherardi; Mariano Esteban
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Simultaneous serodetection of 10 highly prevalent mouse infectious pathogens in a single reaction by multiplex analysis.

Authors:  Imran H Khan; Lon V Kendall; Melanie Ziman; Scott Wong; Sara Mendoza; James Fahey; Stephen M Griffey; Stephen W Barthold; Paul A Luciw
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

7.  Isolation and characterization of a Chinese hamster ovary mutant cell line with altered sensitivity to vaccinia virus killing.

Authors:  C H Bair; C S Chung; I A Vasilevskaya; W Chang
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models.

Authors:  Kilian Guse; Marta Sloniecka; Iulia Diaconu; Kathryn Ottolino-Perry; Nan Tang; Calvin Ng; Fabrice Le Boeuf; John C Bell; J Andrea McCart; Ari Ristimäki; Sari Pesonen; Vincenzo Cerullo; Akseli Hemminki
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Authors:  Bart Jones; Xiaoyan Zhan; Vasiliy Mishin; Karen S Slobod; Sherri Surman; Charles J Russell; Allen Portner; Julia L Hurwitz
Journal:  Vaccine       Date:  2009-02-04       Impact factor: 3.641

10.  Intranodal immunization with a vaccinia virus encoding multiple antigenic epitopes and costimulatory molecules in metastatic melanoma.

Authors:  Michel Adamina; Rachel Rosenthal; Walter P Weber; Daniel M Frey; Carsten T Viehl; Martin Bolli; Rolf W Huegli; Augustinus L Jacob; Michael Heberer; Daniel Oertli; Walter Marti; Giulio C Spagnoli; Paul Zajac
Journal:  Mol Ther       Date:  2009-11-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.